Last Updated: November 9, 2026

Details for Patent: RE28315

Name: Drug Patent Intelligence for US Patent RE28315
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: RE28315

Title:	Cooc.hi
Abstract:	IN WHICH R1 IS A HYDROGEN OR HALOGEN ATOM OR A TRIFLUOROMETHYL, LOWER ALKOXY, NITRO OR AMINO GROUP R2 IS A FURYL, A THIENYL, CYCLOHEXYL, LOWER ALKYL OR A PHENYL GROUP WHICH MAY BE SUBSTITUTED BY A HALOGEN ATOM OR BY A TRIFLUOROMETHYL, NITRO, LOWER ALKOXY OR LOWER ALKYL GROUP, AND R3 IS A HYDROGEN ATOM OR A LOWER ALKYL GROUP, AND R4 IS A LOWER CARBALKOXY, CARBAMOYL, A NLOWERALKYLCARBAMOYL, A N,N-DILOWERALKYLCARBAMOYL, A N(DILOWERALKYLAMINOALKYL) CARBAMOYL, A GROUP HAVING THE FORMULA -COOC AT IN WHICH CAT IS A CATION OF AN ALKALI METAL OR A SEMICATION OF AN ALKALINE EARTH METAL. DIAZEPINE 1-R3,2-(O=),3-R4,5-R2,7-R1-2,3-DIHYDRO-1H-1,4-BENZO- 1. A BENZODIAZEPINE HAVING THE FORMULA
Inventor(s):
Assignee:	Sanofi SA
Application Number:
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent RE28315

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent RE28315

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	268285	⤷ Start Trial
Austria	284084	⤷ Start Trial
Belgium	665401	⤷ Start Trial
Brazil	6570433	⤷ Start Trial
Canada	958707	⤷ Start Trial
Canada	958708	⤷ Start Trial
Switzerland	479552	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.